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Because serosurveys of Japanese encephalitis virus 
(JEV) among wild animals and pigs may not accurately 
reﬂ  ect risk for humans in urban/residential areas, we ex-
amined seroprevalence among dogs and cats. We found 
that JEV-infected mosquitoes have spread throughout Ja-
pan and that dogs, but not cats, might be good sentinels for 
monitoring JEV infection in urban/residential areas.
J
apanese encephalitis virus (JEV), a common cause of se-
rious acute encephalitis in humans, is primarily transmit-
ted by Culex tritaeniorhynchus mosquitoes and is widely 
endemic to Southeast Asia and the Western Paciﬁ  c region 
(1). Annual incidence of Japanese encephalitis (JE) is 
≈50,000 cases,with 10,000 deaths (2). In Japan during the 
1950s, several thousand JE cases occurred each year. How-
ever, as a result of a JEV vaccination program, isolation of 
pig farms, and reduction of mosquitoes, the number of JE 
cases in Japan has decreased markedly, to <10 cases per 
year since 1992 (3). In 2005, the strong recommendation 
for JE vaccination was halted because of a severe vaccine-
associated side effect in 1 person; however, since 2009, a 
newly developed JE vaccine has been available and vac-
cination has been resumed.
Annual serosurveys for JEV antibodies in pigs, the 
main ampliﬁ  ers of JEV, tend to show high seropositivity in 
western Japan (3). Our previous study of JEV in wild ani-
mals in the Kinki district also showed high seroprevalence: 
83% among wild boars and 59% among raccoons (4). These 
data indicate that JEV remains endemic to Japan.
However, serosurveys of wild animals and pigs may 
not accurately reﬂ  ect risk for humans because these ani-
mals remain separate from human populations and thus 
may not indicate the prevalence of JEV in urban/residential 
areas of Japan. Therefore, additional monitoring of the risk 
for JEV infection in humans in these areas, in addition to 
annual surveillance of pigs, is needed. To determine sero-
prevalence in family-owned dogs and cats, which share liv-
ing space with humans, we conducted serosurveys of JEV 
in these species. 
The Study
First, to examine whether dogs and cats were infected 
with JEV, we analyzed serum samples from 100 dogs and 
292 cats in Yamaguchi Prefecture, which is in the western 
part of Honshu, Japan. Dog samples were collected during 
2006–2007, and cat samples were collected during 1997–
1999 and 2004–2005. An 80% plaque-reduction neutraliz-
ing test using virus JEV/sw/Chiba/88/2002 was performed 
as described (4). Virus JEV/sw/Chiba/88/2002 is geneti-
cally classiﬁ  ed as genotype I (5). To analyze the results 
statistically, we performed χ2 and Fisher exact probability 
tests. The signiﬁ  cance level was p<0.05.
Results showed that 17% of dogs and 1% of cats were 
seropositive for JEV; thus, seropositivity was ≈10-fold 
higher among dogs than among cats (Table 1). In addition, 
outdoor-only dogs (38%) were 3.7-fold more likely to be se-
ropositive than were indoor-only dogs (10%) (p<0.05). An-
tibody prevalence did not differ signiﬁ  cantly between male 
(14%) and female (20%) dogs (p>0.05; data not shown). 
Next, serum samples from 652 dogs in every district 
in Japan during 2006–2007 were examined for seropreva-
lence of JEV. The results showed that 25% of dogs had 
virus-neutralizing antibodies against JEV. In northern Ja-
pan, 0% and 9% of dogs from the Hokkaido and Tohoku 
districts, respectively, were seropositive; these  levels were 
signiﬁ  cantly lower than those for other districts (p<0.05). 
In contrast, in southern Japan, 61% and 47% of dogs in 
the Shikoku and Kyushu districts, respectively, were sero-
positive; these levels were signiﬁ  cantly higher than those 
for other districts (p<0.05). Seropositivity to JEV in the 
Kanto (17%), Chubu (18%), Kinki (23%), and Chugoku 
(26%) districts showed no signiﬁ  cant differences (p>0.05) 
(Figure). In addition, 45% of outdoor-only dogs and 
8% of indoor-only dogs were seropositive for JEV, thus 
conﬁ   rming that outdoor-only dogs were 5.5-fold more 
likely than indoor-only dogs to be seropositive (p<0.05) 
(Table 2). Regarding the areas of residence, 21% of dogs in 
urban/residential areas and 43% of dogs in rural areas were 
seropositive; the results for rural areas were signiﬁ  cantly 
higher than those for urban/residential areas (Table 2). No 
signiﬁ  cant correlation was found between ages of dogs and 
JEV seropositivity (data not shown).
Discussion and Conclusions
Our ﬁ  ndings of signiﬁ  cantly higher JEV seropositivity 
among dogs than cats are similar to those found in a 1954–
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seropositive for JEV (6). Studies of another mosquito-vec-
tored virus found 26% of dogs and 9% of cats in Louisiana 
and 5% of dogs and no cats in New York to be seropositive 
for West Nile virus (WNV) (7,8). Previous reports on host 
feeding patterns of JEV and WNV vectors showed that al-
though Culex spp. mosquitoes feed on various mammals, 
including dogs, cats, and humans, they tend to feed more 
on dogs than on cats or humans (9,10). These reports are 
consistent with our ﬁ  nding that seropositivity was higher 
among dogs than among cats and humans and indicate that 
some JEV vectors do occasionally feed on humans.
Our nationwide serosurvey indicated that JEV preva-
lence was signiﬁ  cantly lower in the Hokkaido and To-
hoku districts and signiﬁ  cantly higher in the Kyushu and 
Shikoku districts (Figure). Annual serosurveys of pigs 
have also shown that JEV seropositivity rates are higher for 
pigs in western than in northern Japan. In addition, during 
2005–2007 in Japan, 24 JE cases in humans were reported, 
most of which occurred in western Japan (11). This ﬁ  nding 
is consistent with our data, suggesting that serosurveys in 
dogs accurately reﬂ  ect JEV infection risk for humans in 
Japan.
Our ﬁ  nding that 45% of outdoor-only dogs were se-
ropositive for JEV is similar to the ﬁ  nding of a previous 
study, conducted during a WNV epidemic among humans, 
that 69% of outdoor-only dogs were seropositive for WNV 
(7). A serosurvey in the Kanto district of Tokyo during 
1954–1955 showed that 49% of stray dogs were seroposi-
tive for JEV (6). Results of these studies are similar to our 
results, indicating that risk for JEV infection remains high 
in Japan, particularly in the western part. In addition, con-
ﬁ  rmation of seropositivity among indoor-only dogs (8%) 
indicates that JEV-infected mosquitoes may enter houses; 
thus, infants and elderly persons, who tend to go outside 
less frequently, might also be at risk for JEV infection.
That seropositivity in rural areas (43%) was signiﬁ  -
cantly higher than that in urban/residential areas (21%) 
suggests that pig farms and rice paddies in rural areas are 
associated with JEV. However, the relatively high seropos-
itivity in urban/residential areas suggests that JEV infection 
risk for humans remains high, even in areas with few pig 
farms and rice paddies. Because pigs are housed away from 
humans, serosurveys of pigs in urban/residential areas are 
limited. Therefore, dogs, which are found in all areas of 
Japan, may be better sentinels for JEV infection in these 
areas. However, information such as whether dogs become 
viremic after JEV infection or how long anti-JEV antibod-
ies last in them remains unclear. 
In conclusion, using dogs as sentinels indicated that 
the risk for human infection with JEV remains high, even 
in urban/residential areas. Therefore, to assess the continu-
ing risk for JEV infection in humans in urban/residential 
areas of Japan, we recommend JEV surveillance among 
pigs every year and surveillance among dogs every several 
years.
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Figure. Seropositivity for Japanese encephalitis virus among 
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of seronegative dogs.
Table 1. Seroprevalence of Japanese encephalitis virus among 
dogs (2006–2007) and cats (1997–2005), Yamaguchi, Japan* 
Animals No. examined  No. (%) positive 
Dogs
 Indoor  58 6  (10) 
 Outdoor  21 8  (38) 
  Both or unknown  21 3 (14) 
 Total  100 17  (17) 
Cats 292 3 (1) 
*Housing information obtained by questionnaire. 
Table 2. Seroprevalence of Japanese encephalitis virus among 
dogs throughout Japan, 2006–2007* 
Location No. examined  No. (%) positive 
Where dog stays 
 Indoors  222 18  (8) 
 Outdoors  234 105  (45) 
  Both or unknown  196 41 (21) 
Type of area  
 Urban/residential  405 86  (21) 
 Rural  152 65  (43) 
 Unknown  95 13  (14) 
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